RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
G
CXCL12
C-X-C motif chemokine ligand 12
exacerbates
ISO
protein:increased expression: mucosa of larynx (human)
RGD
PMID:23259294
RGD:152177474
NCBI chr10:41,296,975...41,384,864
Ensembl chr10:44,552,480...44,564,231
G
CXCR4
C-X-C motif chemokine receptor 4
exacerbates
ISO
protein:increased expression: mucosa of larynx (human)
RGD
PMID:23259294
RGD:152177474
NCBI chr2B:23,744,271...23,748,106
Ensembl chr2B:140,181,829...140,189,647
G
ERCC5
ERCC excision repair 5, endonuclease
susceptibility
ISO
DNA:missense mutation:CDS:p.D1104H (human)
RGD
PMID:19444904
RGD:155260337
NCBI chr13:84,005,950...84,036,710
Ensembl chr13:103,096,344...103,174,182
G
ERCC6
ERCC excision repair 6, chromatin remodeling factor
susceptibility
ISO
DNA:missense mutation:CDS:p.R1230P (human)
RGD
PMID:19444904
RGD:155260337
NCBI chr10:44,703,720...44,784,948
G
GPX1
glutathione peroxidase 1
susceptibility
ISO
DNA:missense mutation:CDS: (rs1050450) (human)
RGD
PMID:23516596
RGD:152998903
NCBI chr 3:49,280,038...49,281,455
Ensembl chr 3:50,360,947...50,361,826
G
GSTM1
glutathione S-transferase mu 1
ISO
DNA:deletion: :
RGD
PMID:19252926
RGD:4140943
Ensembl chr 1:127,979,238...128,010,411
G
GSTM3
glutathione S-transferase mu 3
ISO
RGD
PMID:10067818
RGD:5135043
NCBI chr 1:112,380,890...112,384,988
Ensembl chr 1:127,957,008...127,960,578
G
MAP2K7
mitogen-activated protein kinase kinase 7
ameliorates
ISO
mRNA:increased expression:larynx (human)
RGD
PMID:32791689
RGD:155256869
NCBI chr19:7,205,124...7,215,776
Ensembl chr19:8,057,598...8,066,512
G
NOD2
nucleotide binding oligomerization domain containing 2
onset
ISO
DNA:insertion:Cds: 3020_3021insC (human)
RGD
PMID:20223031
RGD:5131515
NCBI chr16:30,955,976...30,995,451
Ensembl chr16:49,837,891...49,873,773
G
VEGFA
vascular endothelial growth factor A
treatment
ISO
RGD
PMID:20967863
RGD:126925200
NCBI chr 6:43,361,053...43,377,366
Ensembl chr 6:44,650,365...44,666,353
G
WRAP53
WD repeat containing antisense to TP53
disease_progression
ISO
RGD
PMID:28849066
RGD:21081521
NCBI chr17:7,715,897...7,735,873
Ensembl chr17:7,707,221...7,723,394
G
ACKR3
atypical chemokine receptor 3
disease_progression
ISO
protein:increased expression:larynx (human)
RGD
PMID:16494043
RGD:152025548
NCBI chr2B:123,795,664...123,810,067
Ensembl chr2B:242,666,173...242,667,261
G
CXCR4
C-X-C motif chemokine receptor 4
disease_progression
ISO
protein:increased expression:larynx (human)
RGD
PMID:16494043
RGD:152025548
NCBI chr2B:23,744,271...23,748,106
Ensembl chr2B:140,181,829...140,189,647
G
KMT2C
lysine methyltransferase 2C
ISO
mRNA:decreased expression:larynx
RGD
PMID:25633166
RGD:151356763
NCBI chr 7:143,714,716...144,016,188
Ensembl chr 7:155,862,610...156,081,043
G
SOCS1
suppressor of cytokine signaling 1
severity
ISO
RGD
PMID:20164024
RGD:150573814
NCBI chr16:10,196,432...10,198,205
G
TRAF6
TNF receptor associated factor 6
disease_progression
ISO
RGD
PMID:20164024
RGD:150573814
NCBI chr11:36,457,633...36,483,616
Ensembl chr11:36,335,609...36,356,334
G
UBR5
ubiquitin protein ligase E3 component n-recognin 5
exacerbates
ISO
mRNA, protein:increased expression:larynx (human)
RGD
PMID:32468011
RGD:151665191
NCBI chr 8:98,904,557...99,064,121
Ensembl chr 8:101,067,435...101,224,913
G
XRCC1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:SNPs, haplotype:: (rs3213403, rs1799778, rs3213282) (human) DNA:missense mutation:cds: p.R280H (human)
RGD
PMID:24956286 PMID:27808358
RGD:151236313 RGD:151236314
NCBI chr19:40,485,052...40,522,188
Ensembl chr19:49,094,014...49,125,520
G
ADA
adenosine deaminase
ISO
protein:decreased activity:larynx
RGD
PMID:8138195
RGD:152995273
NCBI chr20:40,950,238...40,982,481
Ensembl chr20:42,044,613...42,076,868
G
CAT
catalase
ISO
protein:increased activity:larynx
RGD
PMID:8138195
RGD:152995273
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
G
CDC73
cell division cycle 73
disease_progression
ISO
protein:decreased expression:larynx (human)
RGD
PMID:27334641
RGD:150539447
NCBI chr 1:168,581,730...168,710,915
Ensembl chr 1:172,875,365...173,004,934
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
RGD
PMID:15646812
RGD:8662837
NCBI chr 6:36,241,405...36,250,032
Ensembl chr 6:37,436,990...37,445,599
G
CHD4
chromodomain helicase DNA binding protein 4
exacerbates
ISO
mRNA:increased expression:larynx (human)
RGD
PMID:33315534
RGD:153323310
NCBI chr12:6,701,004...6,738,621
Ensembl chr12:6,619,089...6,656,076
G
EGFR
epidermal growth factor receptor
disease_progression
ISO
RGD
PMID:22549618
RGD:126790474
NCBI chr 7:55,614,042...55,807,285
Ensembl chr 7:56,046,296...56,111,615
G
ERBB2
erb-b2 receptor tyrosine kinase 2
disease_progression
ISO
RGD
PMID:22549618
RGD:126790474
NCBI chr17:17,560,337...17,600,808
Ensembl chr17:17,777,434...17,805,862
G
ERBB3
erb-b2 receptor tyrosine kinase 3
disease_progression
ISO
RGD
PMID:22549618
RGD:126790474
NCBI chr12:32,811,533...32,834,958
Ensembl chr12:33,063,434...33,084,994
G
ERBB4
erb-b2 receptor tyrosine kinase 4
disease_progression
ISO
RGD
PMID:22549618
RGD:126790474
NCBI chr2B:98,625,630...99,795,371
Ensembl chr2B:217,069,644...218,272,006
G
FOXL2
forkhead box L2
exacerbates
ISO
mRNA:increased expression:larynx (human)
RGD
PMID:32517588
RGD:151667913
NCBI chr 3:135,968,040...135,980,063
G
GPX1
glutathione peroxidase 1
disease_progression no_association
ISO
protein:increased expression:larynx (human) DNA:missense mutation:CDS:p.P198L (human) DNA:missense mutation:CDS:p.P198L (rs1050450) (human)
RGD
PMID:24074040 PMID:27188866 PMID:28641905
RGD:152995454 RGD:152995455 RGD:152995493
NCBI chr 3:49,280,038...49,281,455
Ensembl chr 3:50,360,947...50,361,826
G
MAP2K4
mitogen-activated protein kinase kinase 4
severity
ISO
associated with Neoplasm Metastasis; protein:mRNA,increased expression:larynx epithelium (human)
RGD
PMID:19513509
RGD:150429781
NCBI chr17:39,497,105...39,622,331
Ensembl chr17:44,248,857...44,359,909
G
MLH1
mutL homolog 1
disease_progression
ISO
mRNA:decreased expression:larynx
RGD
PMID:23787767
RGD:126848783
NCBI chr 3:36,899,828...36,957,076
Ensembl chr 3:37,189,439...37,245,801
G
MMP2
matrix metallopeptidase 2
ISO
RGD
PMID:17786346
RGD:5130203
NCBI chr16:35,711,866...35,738,881
Ensembl chr16:54,812,694...54,844,279
G
MSH2
mutS homolog 2
disease_progression
ISO
mRNA:decreased expression:larynx
RGD
PMID:23787767
RGD:126848783
NCBI chr2A:47,524,468...47,602,376
Ensembl chr2A:48,447,207...48,554,461
G
NAT2
N-acetyltransferase 2
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:16155914 PMID:19922706
RGD:5131602 RGD:5131856
NCBI chr 8:17,606,445...17,623,397
Ensembl chr 8:14,575,455...14,576,327
G
PLCG1
phospholipase C gamma 1
ameliorates
ISO
mRNA:increased expression:larynx (human)
RGD
PMID:33466212
RGD:151665160
NCBI chr20:37,477,077...37,515,854
Ensembl chr20:38,572,709...38,615,145
G
RELA
RELA proto-oncogene, NF-kB subunit
severity
ISO
associated with Neoplasm Metastasis; protein:mRNA,increased expression:larynx epithelium (human)
RGD
PMID:19513509
RGD:150429781
NCBI chr11:61,012,839...61,022,225
Ensembl chr11:64,347,859...64,356,868
G
XDH
xanthine dehydrogenase
ISO
protein:increased activity:larynx
RGD
PMID:8138195
RGD:152995273
NCBI chr2A:31,356,011...31,435,111
Ensembl chr2A:31,425,183...31,504,455
G
XRCC1
X-ray repair cross complementing 1
ISO
ClinVar Annotator: match by term: Laryngeal squamous cell carcinoma
ClinVar
NCBI chr19:40,485,052...40,522,188
Ensembl chr19:49,094,014...49,125,520
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all